Comparison of the biodegradable polymer everolimus-eluting stent with contemporary drug-eluting stents: A systematic review and meta-analysis
- 1 March 2019
- journal article
- review article
- Published by Elsevier in International Journal of Cardiology
- Vol. 278, 51-56
Abstract
No abstract availableKeywords
This publication has 15 references indexed in Scilit:
- Meta-Analysis of Randomized Clinical Trials Comparing Biodegradable Polymer Drug-Eluting Stent to Second-Generation Durable Polymer Drug-Eluting StentsJACC: Cardiovascular Interventions, 2017
- Very thin strut biodegradable polymer everolimus-eluting and sirolimus-eluting stents versus durable polymer zotarolimus-eluting stents in allcomers with coronary artery disease (BIO-RESORT): a three-arm, randomised, non-inferiority trialThe Lancet, 2016
- Final 3-Year Outcome of a Randomized Trial Comparing Second-Generation Drug-Eluting Stents Using Either Biodegradable Polymer or Durable PolymerCirculation: Cardiovascular Interventions, 2015
- Long-Term Safety of Drug-Eluting and Bare-Metal StentsJACC, 2015
- Efficacy and Safety of a Novel Bioabsorbable Polymer-Coated, Everolimus-Eluting Coronary StentCirculation: Cardiovascular Interventions, 2015
- 2014 ESC/EACTS Guidelines on myocardial revascularizationEuropean Heart Journal, 2014
- Biodegradable-polymer drug-eluting stents vs. bare metal stents vs. durable-polymer drug-eluting stents: a systematic review and Bayesian approach network meta-analysisEuropean Heart Journal, 2014
- Impact of Stent Surface on Thrombogenicity and Vascular HealingCirculation: Cardiovascular Interventions, 2013
- Safety and efficacy of biodegradable vs. durable polymer drug-eluting stents: evidence from a meta-analysis of randomised trialsEuroIntervention, 2011
- Preferred Reporting Items for Systematic Reviews and Meta-Analyses: The PRISMA StatementJournal of Clinical Epidemiology, 2009